2-[5-bromo-6-oxo-4-[[(1S,2R,3R,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]carbamoylamino]pyridazin-1-yl]acetic acid

C17H23BrN4O4 — CID 59574800

IUPAC2-[5-bromo-6-oxo-4-[[(1S,2R,3R,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]carbamoylamino]pyridazin-1-yl]acetic acid
SMILESC[C@H]1[C@H](NC(=O)Nc2cnn(CC(=O)O)c(=O)c2Br)C[C@H]2C[C@@H]1C2(C)C
InChIInChI=1S/C17H23BrN4O4/c1-8-10-4-9(17(10,2)3)5-11(8)20-16(26)21-12-6-19-22(7-13(23)24)15(25)14(12)18/h6,8-11H,4-5,7H2,1-3H3,(H,23,24)(H2,20,21,26)/t8-,9-,10+,11-/m1/s1
InChIKeyOQVVQFSBYIPWJS-CHWFTXMASA-N
MW427.30 g/mol
LogP2.28
Rot. Bonds4

About 2-[5-bromo-6-oxo-4-[[(1S,2R,3R,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]carbamoylamino]pyridazin-1-yl]acetic acid

2-[5-bromo-6-oxo-4-[[(1S,2R,3R,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]carbamoylamino]pyridazin-1-yl]acetic acid (PubChem CID 59574800) has the molecular formula C17H23BrN4O4 and a molecular weight of 427.30 g/mol. Its IUPAC name is 2-[5-bromo-6-oxo-4-[[(1S,2R,3R,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]carbamoylamino]pyridazin-1-yl]acetic acid.

Molecular Properties

Compound Name2-[5-bromo-6-oxo-4-[[(1S,2R,3R,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]carbamoylamino]pyridazin-1-yl]acetic acid
PubChem CID59574800
Molecular FormulaC17H23BrN4O4
Molecular Weight427.30 g/mol
Exact Mass426.09
IUPAC Name2-[5-bromo-6-oxo-4-[[(1S,2R,3R,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]carbamoylamino]pyridazin-1-yl]acetic acid
SMILESC[C@H]1[C@H](NC(=O)Nc2cnn(CC(=O)O)c(=O)c2Br)C[C@H]2C[C@@H]1C2(C)C
InChIInChI=1S/C17H23BrN4O4/c1-8-10-4-9(17(10,2)3)5-11(8)20-16(26)21-12-6-19-22(7-13(23)24)15(25)14(12)18/h6,8-11H,4-5,7H2,1-3H3,(H,23,24)(H2,20,21,26)/t8-,9-,10+,11-/m1/s1
InChIKeyOQVVQFSBYIPWJS-CHWFTXMASA-N
XLogP2.28
TPSA113.32 Ų
H-Bond Donors3
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms26
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500427.30
LogP ≤ 52.28
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 105

Analyze 2-[5-bromo-6-oxo-4-[[(1S,2R,3R,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]carbamoylamino]pyridazin-1-yl]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[5-bromo-6-oxo-4-[[(1S,2R,3R,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]carbamoylamino]pyridazin-1-yl]acetic acid?
The IUPAC name of 2-[5-bromo-6-oxo-4-[[(1S,2R,3R,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]carbamoylamino]pyridazin-1-yl]acetic acid (CID 59574800) is 2-[5-bromo-6-oxo-4-[[(1S,2R,3R,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]carbamoylamino]pyridazin-1-yl]acetic acid.
What is the SMILES notation for 2-[5-bromo-6-oxo-4-[[(1S,2R,3R,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]carbamoylamino]pyridazin-1-yl]acetic acid?
The canonical SMILES for 2-[5-bromo-6-oxo-4-[[(1S,2R,3R,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]carbamoylamino]pyridazin-1-yl]acetic acid is C[C@H]1[C@H](NC(=O)Nc2cnn(CC(=O)O)c(=O)c2Br)C[C@H]2C[C@@H]1C2(C)C.
What is the InChIKey of 2-[5-bromo-6-oxo-4-[[(1S,2R,3R,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]carbamoylamino]pyridazin-1-yl]acetic acid?
The InChIKey is OQVVQFSBYIPWJS-CHWFTXMASA-N. The full InChI is InChI=1S/C17H23BrN4O4/c1-8-10-4-9(17(10,2)3)5-11(8)20-16(26)21-12-6-19-22(7-13(23)24)15(25)14(12)18/h6,8-11H,4-5,7H2,1-3H3,(H,23,24)(H2,20,21,26)/t8-,9-,10+,11-/m1/s1.
What are the key properties of 2-[5-bromo-6-oxo-4-[[(1S,2R,3R,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]carbamoylamino]pyridazin-1-yl]acetic acid?
2-[5-bromo-6-oxo-4-[[(1S,2R,3R,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]carbamoylamino]pyridazin-1-yl]acetic acid has a molecular weight of 427.30 g/mol, XLogP of 2.28, 4 rotatable bonds, 3 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[5-bromo-6-oxo-4-[[(1S,2R,3R,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]carbamoylamino]pyridazin-1-yl]acetic acid is sourced from PubChem (CID 59574800), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).